3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: September 11, 2013
Period of Report: September 3, 2013
Accession Number: 0001250853-13-000090

View Document ↗ View on SEC.gov ↗